Home › Johnson & Johnson posts mixed 3Q results, authorizes buyback
 

Keywords :   


Johnson & Johnson posts mixed 3Q results, authorizes buyback

2015-10-13 16:02:19| Biotech - Topix.net

Health care giant Johnson & Johnson posted a 29 percent drop in third-quarter earnings, hammered by plunging sales of its hepatitis C medicine and unfavorable currency exchange rates that reduced the value of overseas sales. Its year-ago results had also included a big gain from selling a diagnostics business.

Tags: results posts johnson mixed

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.05Atlantic Tropical Weather Outlook
28.05Low Environmental Impact Recycled Paints Arrive in Indonesia
28.05Eastern North Pacific Tropical Weather Outlook
28.05Ousted WeWork boss drops effort to return
28.05Baldwin Technology unveils new products at drupa
28.05Royal Mail owners to back 5bn takeover offer
28.05Malaysian printers turns to Vetaphone and Nordmeccanica
28.05Katun DPS promotes digital label printing at drupa
More »